MANAGEMENT TEAM
CEO
Ilan Ganot
An entrepreneur, a leader, and manager, focused on the development of innovative therapies for rare diseases.
CMO
Benit Maru, MBChB, PhD
An academic physician, neuroimmunologist, and health economist with extensive global experience in clinical research and development.
CSO
Matthias Van Woensel, PhD
A science-driven operator focused on developing breakthrough therapeutics for oncology and genetic diseases
Head of Operations
Madhav Gurijala
Life sciences operator focused on early-stage companies, genetic medicines, and investment opportunities.
OUR TEAM
Laurie Smaldone Alsup, MD
Global Regulatory SME
Bjorn Carlsson, PhD
Nonclinical Regulatory SME
Jakub Swiercz, PhD
VP R&D
Meredith Peters
Executive Assistant
Rick Dekker
Victoria Oswald, PhD
Program Manager
Michael Bober, MD, PhD
Medical Director
Aaron Deveney, PhD
Head of Clinical Development
John Dulos, PhD
Sr. VP Translational&Pharmacology
Melissa Albino
Research Associate
Serena ter Kuile
Senior Legal Counsel
Elizabeth Reynolds
Medical Affairs Manager
Anna Avlichou
Anu Gupta
R&D Manager
Heather Paden
Clinical Operations Head
Bram van Raam
Principal Scientist
Syndey Borden
Dani Thomas, MBChB
Head of Medical Affairs & PAD
Wilco Snel, PhD
Director Project Manager
Emmanuel Karouzakis, PhD
Director Translational Biomarkers
Artal Moreno-Fortuny, PhD
Exec. Director, Biz Dev & Strategy
Kevin O'Brien
Principal Scientist, Translational